METTL14 and juvenile myelomonocytic leukemia: The knockout of METTL14 was revealed to significantly promote hematopoietic stem/progenitor cells (HSPCs) expansion and suppresses disease progression in a KrasG12D/+ mutation-induced mouse model of JMML.